Helicobacter pylori: gastric cancer and beyond
Open accessThe DOI matches its Crossref record; 142 of the 144 references it cites were found in a registry or an index.
Abstract
Helicobacter pylori is the dominant species of the human gastric microbiome, and colonization causes a persistent inflammatory response. H. pylori-induced gastritis is the strongest singular risk factor for cancers of the stomach; however, only a small proportion of infected individuals develop malignancy. Carcinogenic risk is modified by strain-specific bacterial components, host responses and/or specific host-microbe interactions. Delineation of bacterial and host mediators that augment gastric cancer risk has profound ramifications for both physicians and biomedical researchers as such findings will not only focus the prevention approaches that target H. pylori-infected human populations at increased risk for stomach cancer but will also provide mechanistic insights into inflammatory carcinomas that develop beyond the gastric niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Similarly, some of these tested pathogens, such as E. coli and H. pylori, are known as initial causes of colon cancers [41,42].”
From Bioprophylactic potential of novel human colostrum probiotics via apoptotic induction of colon cancer cells and cell immune activation (2022) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a standout example, Helicobacter pylori infection is one of GC’s most important risk factors [95].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Correa, P. (1992) · PubMed · Cited by 3,216
Alm, R. A., Ling, L.-S. L., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B., Guild, B. C., deJonge, B. L., et al. (1999) · Nature · doi:10.1038/16495 · Cited by 1,893
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813 · cited 1×
“pylori strain that expressed lex and ley, only bacterial populations recovered from leb-positive mice expressed leb, and this was mediated by a putative galactosyltransferase gene (β‐(1,3)galT)38.”
BackgroundSelf-citationAn Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607 · cited 1×
“Furthermore, the processing and availability of at least three EGFR ligands, HBEGF, transforming growth factor-α ( TGFα ) and amphiregulin ( AREG ), requires ADAM17 expressio”
BackgroundPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435 · cited 1×
“pylori significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesion”
BackgroundTranslocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286 · cited 1×
“The product of the terminal gene in the island (CagA) is translocated into and phosphorylated within host epithelial cells following bacterial attachmen”
BackgroundNod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Mémet, S., Huerre, M. R., Coyle, A. J., et al. (2004) · Nature Immunology · doi:10.1038/ni1131 · Cited by 1,226 · cited 1×
“, where they are sensed by an intracytoplasmic pathogen-recognition molecule nucleotide-binding oligomerization domain-containing protein 1 ( NOD1”
Background
Cited by
Items 501–600 of 1,000
Yamamichi, N., Hirano, C., Ichinose, M., Takahashi, Y., Minatsuki, C., Matsuda, R., Nakayama, C., Shimamoto, T., Kodashima, S., Ono, S., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0558-0 · Cited by 22
“pylori-associated chronic gastritis represents a precancerous condition of the stomach [17, 18].”
BackgroundShi, H., Chen, X., Jiang, H., Wang, X., Yu, H., Sun, P., & Sui, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.7907 · Cited by 22
“Previous findings showed that genetic factors synergize in the development of gastric cancer (4).”
Consenso mexicano sobre detección y tratamiento del cáncer gástrico incipiente
Icaza-Chávez, M. E., Tanimoto, M. A., Huerta-Iga, F. M., Remes-Troche, J. M., Carmona-Sánchez, R., Ángeles-Ángeles, A., Bosques‐Padilla, F., Blancas-Valencia, J. M., Grajales-Figueroa, G., Hernández-Mondragón, O. V., et al. (2019) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2019.10.001 · Cited by 22
“7% para las lesiones tratadas con DESM, con un tiempo promedio del procedimiento de 47 min (8-345).”
BackgroundChen, Y., Pan, K., Li, S., Xia, J., Wang, W., Chen, J., Zhao, J., Lin, L., Wang, D., Pan, Q., et al. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.22150 · Cited by 22
“Most gastric cancers emerge after a long period of chronic atrophic gastritis and intestinal metaplasia, with the single most common cause being Helicobactor pylori infection [2].”
BackgroundLin, L., Huang, H., Ogihara, S., Wang, J.-T., Wu, M.-C., McNeil, P. L., Chen, C., & Juan, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810176 · Cited by 22
“Helicobacter pylori is a gram-negative microaerophilic bacterium that colonizes the gastric epithelium [9].”
BackgroundA review of the toxicology and pathology of the gastrointestinal tract
Betton, G. R. (2013) · Cell Biology and Toxicology · doi:10.1007/s10565-013-9257-y · Cited by 22
“A detailed understanding of these parameters is needed to understand toxicological changes and their potential significance for man.”
BackgroundThe Sodium/Proline Transporter PutP of Helicobacter pylori
Rivera-Ordaz, A., Bracher, S., Sarrach, S., Li, Z., Shi, L., Quick, M., Hilger, D., Haas, R., & Jung, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083576 · Cited by 22
“lymphoid tissue lymphoma of the stomach [1-4].”
Shiryaev, S. A., Aleshin, A. E., Muranaka, N., Kukreja, M., Routenberg, D. A., Remacle, A. G., Liddington, R., Cieplak, P., Ia, K., & Strongin, A. Y. (2014) · FEBS Journal · doi:10.1111/febs.12804 · Cited by 24
“fragilis in increasing colorectal cancer risk is similar to that of Helicobacter pylori in gastric cancer [27, 28].”
Rodent Intestinal Epithelial Carcinogenesis: Pathology and Preclinical Models
Ward, J. M., & Treuting, P. M. (2013) · Toxicologic Pathology · doi:10.1177/0192623313505156 · Cited by 22
Oh, S., Kim, J., Shin, C. M., Lee, H., Lee, H. S., & Park, K. U. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-05989-9 · Cited by 21
“Cancer has also drawn attention because Helicobacter pylori was classified as a class-I carcinogen by the World Health Organization based on its ability to promote stomach cancer after chronic infection [20, 21].”
The Implication of Gastric Microbiome in the Treatment of Gastric Cancer
Pappas‐Gogos, G., Tepelenis, K., Fousekis, F., Katsanos, K. H., Pitiakoudis, M. S., & Vlachos, K. (2022) · Cancers · doi:10.3390/cancers14082039 · Cited by 23
“This is true, for example, of Helicobacter pylori, hich has been found to contribute to the development of GC and MALT lymphoma through chronic inflammation [16,17].”
BackgroundXiao, W., & Ma, Z. S. (2022) · Helicobacter · doi:10.1111/hel.12899 · Cited by 21
Lin, M., Tu, R., Wu, S.-Z., Zhong, Q., Weng, K., Wu, Y.-K., Lin, G., Wang, J., Zheng, C., Xie, J., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06885-2 · Cited by 21
“…[11], long-term chronic HP infection may affect cancer stem cell populations in several ways, including altering the differentiation state of epithelial cells, triggering epigenetic changes such as DNA methylation, and initiating in fl ammatory and immune responses in the microenvironment [12 – 16].”
BackgroundTumor necrosis factor-α 238 G/A polymorphism and gastric cancer risk: a meta-analysis
Yu, J., Li, L., Ma, H., Liu, K., Cheng, X., Li, Y.-L., & Song, X. (2013) · Tumor Biology · doi:10.1007/s13277-013-0972-z · Cited by 21
“pylori infection has been identified as the major risk factor of gastric cancer [2, 3].”
BackgroundInfluentialHimaya, S. W. A., Dewapriya, P., & Kim, S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.03.020 · Cited by 21
Rossi, A. F. T., Duarte, M. C., Poltronieri-Oliveira, A. B., Valsechi, M. C., Jorge, Y. C., Neto, D. D.-S., Rahal, P., Oliani, S. M., & Silva, A. E. (2014) · Mediators of Inflammation · doi:10.1155/2014/478138 · Cited by 21
“Such bacteria populations are heterogeneous and contain virulence factors such as cagA (cytotoxin-associated gene A antigen), which produces a protein that acts in many cellular events such as cytoskeleton rearrangement, cellular polarity breaking, and mitogenic and proapoptotic responses [10].”
BackgroundHuang, L. H., Wang, Z., & Pan, D. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4665 · Cited by 23
“pylori strains are often subdivided into two types according to the cytotoxin-associated gene (Cag) pathogenicity island-encoded CagA protein (12).”
BackgroundHelicobacter pylori Infection of Primary Human Monocytes Boosts Subsequent Immune Responses to LPS
Frauenlob, T., Neuper, T., Mehinagic, M., Dang, H.-H., Boraschi, D., & Horejs‐Hoeck, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847958 · Cited by 21
Esophageal intraepithelial invasion of Helicobacter pylori correlates with atypical hyperplasia
Li, W., Tian, D., Guan, X., Yun, H., Wang, H., Xiao, Y., Bi, C., Ying, S., & Su, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28588 · Cited by 21
Advances in the treatment of Helicobacter pylori infection in children.
Kalach, N., Bontems, P., & Cadranel, S. (2015) · PubMed Central · Cited by 21
Proton Pump Inhibitors and Helicobacter Pylori-Associated Pathogenesis
Hagiwara, T., Mukaisho, K., Nakayama, T., Hattori, T., & Sugihara, H. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.4.1315 · Cited by 21
Hu, Y., Zhao, M., Lu, Z., Lv, F., Zhao, H., & Bie, X. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104856 · Cited by 21
Ethnic Disparities in Early-Onset Gastric Cancer: A Population-Based Study in Texas and California
Tavakkoli, A., Pruitt, S. L., Hoang, A. Q., Zhu, H., Hughes, A. E., McKey, T. A., Elmunzer, B. J., Kwon, R. S., Murphy, C. C., & Singal, A. G. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0210 · Cited by 20
RUNX3 Meets the Ubiquitin-Proteasome System in Cancer
Toska, A., Modi, N., & Chen, L. (2023) · Cells · doi:10.3390/cells12050717 · Cited by 20
“pylori is attributed to its virulence factors, notably cytotoxin-associated gene A (CagA) located in the cag pathogenicity island (cagPAI) [64,65].”
BackgroundInfluentialThe Influence of the Microbiome on Immunotherapy for Gastroesophageal Cancer
Dadgar, N., Keshava, V. E., Raj, M. S., & Wagner, P. L. (2023) · Cancers · doi:10.3390/cancers15184426 · Cited by 21
“Mechanistically, H. pylori -related changes in the tumor microenvironment contribute to tumor progression and immune tolerance by causing chronic inflammation [61], ge-netic alteration including DNA methylation and chromosmomal instability [62–64], and immune suppression [65].”
BackgroundPractical treatment of Helicobacter pylori: a balanced view in changing times
Smith, S. M., Haider, R. B., O'Connor, H. J., McNamara, D. A., & O'Morain, C. A. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000130 · Cited by 20
Balhouse, B. N., Patterson, L., Schmelz, E. M., Slade, D. J., & Verbridge, S. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180372 · Cited by 22
“Beyond the effects of pathogenic or tumorigenic bacteria such as Chlamydophila 56 pneumonia, Salmonella typhi, Streptococcus gallolyticus (5), Helicobacter pylori (6) and 57 Fusobacterium nucleatum (7), the majority of analyses of tumor-microbiome interactions have 58 centered on local cell-cell interactions within th…”
Shang, W., Liang, X., Li, S., Li, T., Zheng, L., Shao, W., Wang, Y., Liu, F., Ma, L., & Jia, J. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102672 · Cited by 20
Kuźmycz, O., & Stączek, P. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1736483 · Cited by 21
“Chronic inflammation, caused by Helicobacter colonization, can induce abnormal Wnt/βcatenin signaling pathway activation, which plays a critical role in cell differentiation, proliferation, growth, and survival.(22,23) Fusobacterium nucleatum exists in the oral cavity of healthy people, however, it may also promote hu…”
BackgroundWhen human cells meet bacteria: precision medicine for cancers using the microbiota.
Zhang, H., & Sun, L. (2018) · Europe PMC (PubMed Central) · Cited by 22
The role of claudin-4 in the development of gastric cancer
Liu, W., & Li, M. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1795923 · Cited by 20
Rao, X., Liu, X., Jia, R., Feng, Y., Zhang, Z., Zhou, L., Han, G., Wang, Z., Cen, R., Shi, N., et al. (2021) · Helicobacter · doi:10.1111/hel.12847 · Cited by 21
Rusin, A., Seymour, C. B., Cocchetto, A. M., & Mothersill, C. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020691 · Cited by 22
“For example, Helicobacter pylori can cause gastric cancers via chronic inflammation of stomach mucosa and the secretion of carcinogenic virulence factors [68,69].”
BackgroundHorizontal Gene Transfers with or without Cell Fusions in All Categories of the Living Matter
Sinkovics, J. G. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0782-5_2 · Cited by 22
“Since the observation of cytoplasmic vacuolization in gastric mucosal cells by Hp toxin to the documentation of oncogene mutations in these cells only 13 years went by [631] [632] [633] .”
BackgroundA possible role of cIAP2 in Helicobacter pylori-associated gastric cancer
Li, Z., Chen, J., Chan, K. W., Qiao, L., & Yu, W. B. C. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.007 · Cited by 20
Zhang, Q.-J., & Yue, L. (2016) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v14i1.28 · Cited by 20
“These activate NF-p50, and p65 subunits translocate into nucleus from cytosol to transcribe several downstream inflammatory factor genes like IL-1β, IL-8, and TNF-α (Sokolova et al., 2013; Polk and Peek, 2010; Yong et al. 2015).”
BackgroundChang, Y., Cheng, T., Yang, X., Jin, L., Sun, H., & Li, H. (2017) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-017-1452-5 · Cited by 20
Chauhan, N. S., Monika, Kumar, T., Sharma, P., & Goyal, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817193-6.00005-4 · Cited by 27
TRP channels in cancer: Therapeutic opportunities and research strategies
Xu, J., Wang, Z., Niu, Y., Tang, Y., Wang, Y., Huang, J., & Leung, E. L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107412 · Cited by 19
Rafiei, A., Hosseini, V., Janbabai, G., Fazli, B., Âjami, A., Hosseini‐khah, Z., Gilbreath, J., & Merrell, D. S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i35.4917 · Cited by 19
Asl, D. H., Farivar, T. N., Rahmani, B., Hajmanoochehri, F., Razavi, À. E., Jahanbin, B., Dodaran, M. S., & Peymani, A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.10.039 · Cited by 21
Li, J., Zakariah, M., Malik, A., Ola, M. S., Syed, R., Chaudhary, A. A., & Khan, S. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s258037 · Cited by 19
Cuomo, P., Papaianni, M., Capparelli, R., & Medaglia, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073706 · Cited by 21
Pratt, M., Forbes, J. D., Knox, N., Domselaar, G. V., & Bernstein, C. N. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.287 · Cited by 19
Santibáñez, M., Aguirre, E., Belda, S., Aragonés, N., Sáez, J., Rodríguez, J. C., Galiana, A., Solá-Vera, J., Ruiz‐García, M., Paz‐Zulueta, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120444 · Cited by 19
“This different patterns of evolution may be related to the host’s characteristics (genetic, immunological), environmental exposures (socio-sanitary and lifestyle factors), and also to certain characteristics of the microorganism [1].”
BackgroundGastric cancer progression associated with local humoral immune responses
López‐Vidal, Y., Ponce‐de‐León, S., Esquivel‐Solís, H., Isabel, A.-F. R., Barreto‐Zúñiga, R., Torre-Delgadillo, A., & Castillo-Rojas, G. (2015) · BMC Cancer · doi:10.1186/s12885-015-1858-9 · Cited by 19
“pylori infection is acquired mainly in the first years of life and persists for decades, causing chronic gastritis, duodenal ulcers, and gastric ulcers, and is a significant risk factor for the development of gastric adenocarcinoma [2].”
Gastric cancer in Latin America
Ruíz‐García, E., Guadarrama-Orozco, J. A., Vidal-Millán, S., Lino-Silva, L. S., López‐Camarillo, C., & la Vega, H. A. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1417473 · Cited by 19
Mucito-Varela, E., Castillo-Rojas, G., Calva, J. J., & López‐Vidal, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.525335 · Cited by 18
“Keywords: Helicobacter pylori, gastric cancer, virulence factor, integrative and conjugative elements (ICE), comparative genomics INTRODUCTION Helicobacter pylori is a gram-negative bacterium that inhabits the gastric mucosa of nearly 50% of the world’s population (Polk and Peek, 2010).”
BackgroundAkbari, A., Varnosfaderani, S. M. N., Haeri, M. S., Fathi, Z., Aziziyan, F., Rad, A. Y., Zalpoor, H., Nabi‐Afjadi, M., & Malekzadegan, Y. (2023) · Human Cell · doi:10.1007/s13577-023-00996-2 · Cited by 18
“…risk of both diffuse-type and intestinal-type gastric adenocarcinoma, only chronic inflammation is not responsible for diffuse-type cancers’ development and progression, suggesting that the mechanisms underlying H. pylori ’s ability to cause malignancy differ for these cancer types [15, 17].”
Lai, C.-H., Huang, J.-C., Chiang-Ni, C., Li, J., Wu, L.-T., Wu, H.-S., Sun, Y.-C., Lin, M.-L., Lee, J.-F., & Lin, H. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/7521913 · Cited by 18
Zhang, W., Xiaohong, D., Zhou, X., Hao, Y., & Li, Y. (2018) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2017-0113 · Cited by 19
Wei, K., Chou, J., Chen, Y.-C., Jin, H., Chuang, Y., Wu, C., & Chan, M. W. Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218338 · Cited by 18
Gao, X., Zhong, S., Tong, Y., Liang, Y., Feng, G., Zhou, X., Zhang, Z., & Huang, G. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152831 · Cited by 18
Mwangi, C., Njoroge, S., Tshibangu‐Kabamba, E., Moloo, Z., Rajula, A., Devani, S., Matsumoto, T., Kimang’a, A. N., Kariuki, S., Revathi, G., et al. (2020) · Toxins · doi:10.3390/toxins12090556 · Cited by 18
“Helicobacter pylori is a Gram-negative bacillus colonizing half of the world’s population [1,2] and is associated with severe gastro-duodenal diseases, including chronic gastritis, peptic ulcer disease, lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) and gastric adenocarcinoma [3].”
BackgroundElagan, S. K., Almalki, S. J., Alharthi, M. R., Mohamed, M. S., & El‐Badawy, M. F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s309051 · Cited by 18
Exploring phage engineering to advance nanobiotechnology
Jiang, H., Li, Y., Cosnier, S., Yang, M., Sun, W., & Mao, C. (2022) · Materials Today Nano · doi:10.1016/j.mtnano.2022.100229 · Cited by 18
Synthesis of the Tetracyclic Core of Exiguaquinol
Schwarzwalder, G. M., Steinhardt, S. E., Pham, H. V., Houk, K. N., & Vanderwal, C. D. (2013) · Organic Letters · doi:10.1021/ol402905n · Cited by 18
Tharmalingam, N., Park, M., Lee, M. H., Woo, H. J., Kim, H. W., Yang, J. Y., Rhee, K.-J., & Kim, J. B. (2016) · PubMed · Cited by 18
Li, D., Zeng, Z., Li, X., Guo, Q., Yuan, L., Zhang, X., Zhai, L., Xia, L., Leng, W., & Qin, S. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08029-6 · Cited by 17
“It is currently clear that Helicobacter pylori (Hp.) infection is an important risk factor for gastric carcinogenesis [6].”
Bisset, K. R., Alam, M., Bassaganya-Riera, J., Carbo, A., Eubank, S., Hontecillas, R., Hoops, S., Mei, Y., Wendelsdorf, K. V., Xie, D., et al. (2012) · IEEE International Parallel and Distributed Processing Symposium (IPDPS) · doi:10.1109/ipdps.2012.15 · Cited by 17
Gao, J., Yu, T., Xuan, Y., & Zhu, Z. (2020) · Translational Cancer Research · doi:10.21037/tcr-19-2914 · Cited by 17
“pylori contributed to GC progression via aberrant activation of key signaling pathways such as mitogen-activated protein kinase (MAPK) cascade (29).”
BackgroundHelicobacter pylori Chronic Infection Selects for Effective Colonizers of Metaplastic Glands
O'Brien, V. P., Jackson, L. K., Frick, J. P., Martinez, A. E. R., Jones, D. S., Johnston, C. D., & Salama, N. R. (2023) · mBio · doi:10.1128/mbio.03116-22 · Cited by 17
“(B) At the indicated weeks after TMX treatment (1) or sham injection (2), mice were infected with PMSS1 for 1 week.”
BackgroundMethodInfluentialThe animal's microbiome and cancer: A translational perspective
Aluai‐Cunha, C., Pinto, C. A., Correia, A., Serra, C. R., & Santos, A. A. F. (2023) · Veterinary and Comparative Oncology · doi:10.1111/vco.12892 · Cited by 17
Phenyl lactic acid alleviates Helicobacter pylori infection in C57BL/6 mice
Wu, S., Cui, W., Zhou, Q., Liang, Y., Wu, D., Xu, Y. Y., Li, P., & Gu, Q. (2023) · Food & Function · doi:10.1039/d3fo00099k · Cited by 18
Dual‐Targeted Graphitic Cascade Nanozymes for Recognition and Treatment of Helicobacter pylori
Deng, H. Y., Zhang, Y., Cai, X., Yin, Z., Yang, Y., Dong, Q., Qiu, Y., & Chen, Z. (2023) · Small · doi:10.1002/smll.202306155 · Cited by 22
Liu, L., Guo, Y., Wang, B., Pan, Y., Zhao, C., Xiao, Z., Liu, Y., Yu, G., Chen, X. S., & Rao, L. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100072 · Cited by 19
Screening and Risk Stratification for Barrett's Esophagus
di Pietro, M., & Fitzgerald, R. C. (2013) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.11.006 · Cited by 17
Multidimensional Identification of Tissue Biomarkers of Gastric Cancer
Guo, T., Fan, L., Ng, W. H., Zhu, Y., Ho, M., Wan, W., Lim, K. H., Ong, W. S., Lee, S. S., Huang, S., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300212g · Cited by 17
Chronic inflammation and gastrointestinal cancer
Watanabe, M., Ida, S., & Baba, H. (2015) · Journal of Cancer Metastasis and Treatment · doi:10.4103/2394-4722.166994 · Cited by 17
Helicobacter pylori and Gastric Cancer
Abadi, A. T. B. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00036 · Cited by 17
Gastric Adenocarcinoma: A Multimodal Approach
Quadri, H. S., Smaglo, B. G., Morales, S. J., Phillips, A. C., Martin, A. D., Chalhoub, W. M., Haddad, N., Unger, K. R., Levy, A. D., & Al‐Refaie, W. B. (2017) · Frontiers in Surgery · doi:10.3389/fsurg.2017.00042 · Cited by 17
Kim, S. H., & Kim, H. (2021) · Nutrients · doi:10.3390/nu13124281 · Cited by 17
“RNA-Seq results revealed that interleukin 8 (gene symbol, CXCL8), chemokine ligand 2 (CXCL1), macrophage inflammatory protein 2 (CXCL2), EGFR, heparinbinding EGF-like growth factor (HBEGF), transforming growth factor-β1 (TGFB1), Smox (SMOX), NF-κB (NFKB1 and NFKB2), TNF-α induced proteins (TNFAIP2 and TNFAIP3), TNF-α…”
BackgroundInfluentialKaempferol inhibits the growth of Helicobacter pylori in a manner distinct from antibiotics
Yang, R., Li, J., Wang, J., Wang, Y., Ma, F., Zhai, R., & Li, P. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14210 · Cited by 17
RUNX3 inhibits survivin expression and induces cell apoptosis in gastric cancer
Liu, Z., Zhang, X., Xu, X., Chen, L., Li, W., Yu, H., Sun, Y., Zeng, J., & Jia, J. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.02.002 · Cited by 17
Genetic diversity of the Helicobacter pylori sialic acid-binding adhesin (sabA) gene.
Shao, L., Takeda, H., Fukui, T., Mabe, K., Han, J., Kawata, S., 大谷, 勝., & Fukao, A. (2010) · PubMed · Cited by 20
O’Rourke, F., Mändle, T., Urbich, C., Dimmeler, S., Michaelis, U. R., Brandes, R. P., Floetenmeyer, M., Döring, C., Hansmann, M., Lauber, K., et al. (2015) · Cellular Microbiology · doi:10.1111/cmi.12447 · Cited by 18
“Over the years, several bacterial species as well as interactions with the microbiome have been linked to pathological tissue growth and in particular the development of carcinogenesis (Dutta et al., 2000; Polk and Peek, 2010; Schwabe and Jobin, 2013).”
BackgroundGut microbiome and gastric cancer: microbial interactions and therapeutic potential
El-Ghannam, M., Hassanien, M. H., Ameen, Y. A., Turky, E. A., ELattar, G. M., Ray, A. A. E., & Eltalkawy, M. D. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00729-w · Cited by 16
“Hp plays a role in oncogenesis at the gastric level through three mechanisms [45].”
Ca2+-calmodulin signalling at the host-pathogen interface
Wanford, J. J., & Odendall, C. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102267 · Cited by 16
Qu, B., Liu, J., Peng, Z., Xiao, Z., Li, S., Wu, J., Li, S., & Luo, J. (2023) · Gene · doi:10.1016/j.gene.2023.147733 · Cited by 17
Cisplatin and doxorubicin chemotherapy alters gut microbiota in a murine osteosarcoma model
Tian, Z., Qiao, X., Wang, Z., Li, X., Pan, Y., Wei, X., Lv, Z., Li, P., Du, Q., Wei, W., et al. (2024) · Aging · doi:10.18632/aging.205428 · Cited by 16
“Recently, studies have found that the microbiome is closely associated with the occurrence and development of various cancers; for example, Helicobacter pylori is recognized by the World Health Organization as a type I carcinogen and is the strongest single risk factor for gastric cancer [7].”
BackgroundKusano, C., Gotoda, T., Ishikawa, H., Suzuki, S., Ikehara, H., & Matsuyama, Y. (2024) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2024.01.022 · Cited by 17
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals
Boston, R. H., Guan, R., Kalmár, L., Beier, S., Horner, E. C., Beristain‐Covarrubias, N., Yam‐Puc, J. C., Gerber, P. P., Faria, L., Kuroshchenkova, A., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202302529 · Cited by 18
“We also found no presence of Helicobacter pylori , which is strongly associated with the initiation and development of gastric cancers (17).”
BackgroundPopovic, A., Cao, E. Y., Han, J., Nursimulu, N., Alves‐Ferreira, E. V. C., Burrows, K., Kennard, A., Alsmadi, N., Grigg, M. E., Mortha, A., et al. (2024) · The ISME Journal · doi:10.1093/ismejo/wrae023 · Cited by 17
“The majority of these reads mapped to Helicobacteraceae (especially Helicobacter ganmani and Helicobacter rodentium ) previously associated with enteric inflammation and exacerbated colitis [ 6, 13, 56].”
Genetic variants and risk of gastric cancer: a pathway analysis of a genome-wide association study
Lee, J. H., Kim, Y., Choi, J.-W., & Kim, Y. (2015) · SpringerPlus · doi:10.1186/s40064-015-1005-8 · Cited by 16
Structural Insights into Helicobacter pylori Cag Protein Interactions with Host Cell Factors
Bergé, C., & Terradot, L. (2017) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-50520-6_6 · Cited by 16
Kino, H., Nakano, M., Kanamori, A., Suzuki, T., Kaneko, Y., Tsuchida, C., Tsuchida, K., Tominaga, K., Sasai, T., Yamagishi, H., et al. (2017) · Internal Medicine · doi:10.2169/internalmedicine.9359-17 · Cited by 16
The Type IV Secretion System in Helicobacter Pylori
Yuan, X., Wang, Y., & Wang, M. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0038 · Cited by 16
Holmes, L., Rios, J., Berice, B. N., Benson, J. A., Bafford, N., Parson, K., & Halloran, D. R. (2021) · Medicines · doi:10.3390/medicines8010001 · Cited by 16
“pylori in gastric adenocarcinoma, demonstrating its role in up to 75% of non-cardia gastric malignancies and up to 98% of gastric cardia malignancies [4].”
BackgroundHe, H., Liu, J., Li, L., Gui, Q., Hao, D., Li, M., Zhang, Y., Hong, X., Xu, J., & Yan, D. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000234 · Cited by 16
McClurg, U. L., Danjo, K., King, H. O., Scott, G. B., Robinson, P. A., & Crabtree, J. E. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.11.011 · Cited by 16
Evidence for Contributions of Gut Microbiota to Colorectal Carcinogenesis
Culpepper, B. S. T., & Mai, V. (2012) · Current Nutrition Reports · doi:10.1007/s13668-012-0032-0 · Cited by 18
“The discovery that Helicobacter pylori is causally associated with non-cardia stomach cancers spurred interest in the potential contribution of this and other infectious agents in intestinal cancers [64].”
BackgroundFunctional profile of gastric epithelial cells infected with Helicobacter pylori strains
Zhang, Y., Sun, H., Chen, X., Li, J. J., Zhao, H., Li, G., & Li, B. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.03.007 · Cited by 16
Yang, W., Sun, H., Sun, H., Yuan, H., Li, B., Li, H., Hu, J., Yang, Y., Zou, Q., Guo, H., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.09.007 · Cited by 16
Biofilms: A cause for the development of cancer: A review
Gupta, A., Bhattacharya, D., Elayaperumal, S., Sivamani, Y., Lahiri, D., & Nag, M. (2025) · The Microbe · doi:10.1016/j.microb.2025.100236 · Cited by 16
Role of Gut Microbiome in Oncogenesis and Oncotherapies
Peddireddi, R. S. S., Kuchana, S. K., Kode, R., Khammammettu, S., Koppanatham, A., Mattigiri, S., Gobburi, H., & Alahari, S. K. (2025) · Cancers · doi:10.3390/cancers18010099 · Cited by 15
“The combined effect is chronic gastritis progressing to atrophy, metaplasia, and adenocarcinoma [36].”
Youssefi, M., Ghazvini, K., Farsiani, H., Tafaghodi, M., & Keikha, M. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100650 · Cited by 17
Marwaha, S., Schumacher, M. A., Zavros, Y. L., & Eghbalnia, H. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111338 · Cited by 16
“Effector molecule PGN (peptidogylcan) is sensed by intracellular receptor NOD1 (nucleotide-binding oligomerization domain 1) [25,33] which activates NFkB [25,33,35,40], ERK, p38 and AP-1 [40].”
BackgroundInfluentialHashinaga, M., Suzuki, R., Akada, J. K., Matsumoto, T., Kido, Y., Okimoto, T., Kodama, M., Murakami, K., & Yamaoka, Y. (2016) · Gut Pathogens · doi:10.1186/s13099-016-0137-x · Cited by 15
Blaser, M. J., & Chen, Y. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx279 · Cited by 17
Neddermann, M., & Backert, S. (2019) · Cellular Microbiology · doi:10.1111/cmi.13022 · Cited by 15
“In some cases, however, the infection causes more severe gastric disorders wileyonlinelibrary.com such as peptic ulcer disease, mucosa‐associated lymphoid tissue lymphoma, and adenocarcinoma (Figueiredo, Costa, Karameris, & Machado, 2015; Polk & Peek, 2010).”
Background
Metadata
- Authors
- Polk, D. B., & Peek, R. M.
- Affiliations
- University of Southern California (US)
- Vanderbilt University (US)
- Corresponding author
- Peek, Richard M.
- Venue
- Nature Reviews Cancer
- Published
- 2010-06
- Volume
- 10
- Issue
- 6
- Pages
- 403-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2957472
- OpenAlex
- W1998630067
- Cited by
- 1,158
- References
- 144
- Citations by year
- 2026: 66 · 2025: 71 · 2024: 74 · 2023: 86 · 2022: 74 · 2021: 80 · 2020: 73 · 2019: 66 · 2018: 72 · 2017: 58 · 2016: 83 · 2015: 68 · 2014: 70 · 2013: 79 · 2012: 72
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA077955, P01CA116087)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058587)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Helicobacter pylori, gastric adenocarcinoma, inflammatory carcinogenesis, host-microbe interactions, gastritis, gastric microbiota, cancer risk factors, cancer prevention
- MeSH terms
- Animals, Humans, Risk Factors, Stomach Neoplasms, Signal Transduction, Helicobacter pylori, Helicobacter Infections, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.